MarketPeel
Insider Trading Intelligence
YC

Yekaterina Chudnovsky

ELTX
DIRECTOR · ELICIO THERAPEUTICS, INC. · CIK 0001979324
FILING MIX · LIFETIME94%/6%
BUYS
16
SELLS
1
TOTAL VALUE
$81.37M
COMPANIES
2
ACTIVE SINCE
Aug 2023
HOLDINGS NOW
115,725
AVG SELL PX
$5.81
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Yekaterina Chudnovsky, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%+5.07%+1.94%+3.13%+1.08%
14d5+100.00%+10.16%+2.07%+8.09%+8.29%
30d5+60.00%+5.05%+0.62%+4.43%+19.85%
60d5+40.00%+5.83%+4.59%+1.24%-5.38%
90d5+100.00%+16.30%+8.05%+8.24%+13.01%
180d5+80.00%+26.80%+12.29%+14.51%+16.29%
1y5+80.00%+60.15%+17.44%+42.71%+78.16%
2y5(1 pending)+50.00%+27.00%+36.09%-9.09%-29.12%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ELTX · 103,225 shares · as of Jun 3, 2025
01,354,0532,708,1064,062,1595,416,21220242025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 1 sellsCOVERAGE · 12 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IMMX
IMMIX BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
12,50012,500May 22, 2026May 29, 2026View →
IMMX
IMMIX BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
6,2506,250May 22, 2026May 29, 2026View →
IMMX
IMMIX BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
33,00033,000Jun 20, 2025Jun 23, 2025View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
103,225103,225Jun 3, 2025Jun 4, 2025View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
7,9007,900May 19, 2025May 20, 2025View →
ELTX
ELICIO THERAPEUTICS, INC.
SALE
3,442,341$5.81$20.00M0Mar 5, 2025Mar 6, 2025View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASE
3,500,573$5.81$20.34M5,416,212Mar 5, 2025Mar 6, 2025View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,1004,100Nov 21, 2024Nov 25, 2024View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASE
3,442,341$5.81$20.00M3,442,341Aug 12, 2024Aug 14, 2024View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASE
1,600,000$4.99$7.98M1,600,000Jun 28, 2024Jul 2, 2024View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASE
1,600,0001,600,000Jun 28, 2024Jul 2, 2024View →
IMMX
IMMIX BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
33,00033,000Jun 11, 2024Jun 21, 2024View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASE
1,032,702$5.81$6.00M1,032,702Mar 19, 2024Mar 20, 2024View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
4,1004,100Dec 28, 2023Dec 28, 2023View →
ELTX
ELICIO THERAPEUTICS, INC.
PURCHASE
1,213,000$5.81$7.05M1,915,639Dec 22, 2023Dec 26, 2023View →
IMMX
IMMIX BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
20,00020,000Aug 22, 2023Aug 23, 2023View →
IMMX
IMMIX BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
16,67016,670Aug 22, 2023Aug 23, 2023View →
Other insiders · ELTX
Loading peer insiders…
About this filer
CIK 0001979324
ROLE
Director
PRIMARY
ELTX
COMPANIES
2
ACTIVE SINCE
Aug 2023
MARKETPEEL · /INSIDER/0001979324DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback